SummaryThe discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols for their cell-type-specific differentiation have revolutionized our approach to cell therapy. It has now become critical to address the challenges related to the generation of iPSCs under current good manufacturing practice (cGMP) compliant conditions, including tissue sourcing, manufacturing, testing, and storage. Furthermore, regarding the technical challenges, it is very important to keep the costs of manufacturing and testing reasonable and solve logistic hurdles that permit the global distribution of these products. Here we describe our efforts to develop a process for the manufacturing of iPSC master cell banks (MCBs) under cGMP...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
The discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols ...
SummaryThe discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of pro...
The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has re...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare...
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
The discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols ...
SummaryThe discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of pro...
The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has re...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
<p>The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has...
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare...
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...